論文 - 森瀬 昌宏
-
Prospective registry database of patients with malignant mesothelioma: directions for a future Japanese registry-based lung cancer study 査読有り 国際誌
Shintani Yasushi, Hasegawa Seiki, Takuwa Teruhisa, Aoe Keisuke, Kato Katsuya, Fujimoto Nobukazu, Hida Yasuhiro, Morise Masahiro, Moriya Yasumitsu, Morohoshi Takao, Okumura Meinoshin, Yoshino Ichiro
JOURNAL OF THORACIC DISEASE 10 巻 ( 3 ) 頁： 1968 - 1971 2018年3月
-
Patients With Antithyroid Antibodies Are Prone To Develop Destructive Thyroiditis by Nivolumab: A Prospective Study 査読有り 国際誌
Kobayashi Tomoko, Iwama Shintaro, Yasuda Yoshinori, Okada Norio, Tsunekawa Taku, Onoue Takeshi, Takagi Hiroshi, Hagiwara Daisuke, Ito Yoshihiro, Morishita Yoshiaki, Goto Motomitsu, Suga Hidetaka, Banno Ryoichi, Yokota Kenji, Hase Tetsunari, Morise Masahiro, Hashimoto Naozumi, Ando Masahiko, Kiyoi Hitoshi, Gotoh Momokazu, Ando Yuichi, Akiyama Masashi, Hasegawa Yoshinori, Arima Hiroshi
JOURNAL OF THE ENDOCRINE SOCIETY 2 巻 ( 3 ) 頁： 241 - 251 2018年3月
-
Tanaka Ichidai, Kawada Kenji, Morise Masahiro, Hase Tetsunari, Hayashi Hiroaki, Sokai Akihiko, Fukatsu Asuki, Kondo Masashi, Nomura Fumio, Hasegawa Yoshinori
CANCER CHEMOTHERAPY AND PHARMACOLOGY 81 巻 ( 2 ) 頁： 339 - 345 2018年2月
-
Sato Mitsuo, Matsui Akira, Shimoyama Yoshie, Omote Norihito, Morise Masahiro, Hase Tetsunari, Tanaka Ichidai, Suzuki Kojiro, Hasegawa Yoshinori
Internal Medicine 57 巻 ( 23 ) 頁： 3429 - 3432 2018年
-
Identification of proteasomal catalytic subunit PSMA6 as a therapeutic target for lung cancer 査読有り 国際共著 国際誌
Kakumu Tomohiko, Sato Mitsuo, Goto Daiki, Kato Toshio, Yogo Naoyuki, Hase Tetsunari, Morise Masahiro, Fukui Takayuki, Yokoi Kohei, Sekido Yoshitaka, Girard Luc, Minna John D., Byers Lauren A., Heymach John V., Coombes Kevin R., Kondo Masashi, Hasegawa Yoshinori
CANCER SCIENCE 108 巻 ( 4 ) 頁： 732 - 743 2017年4月
-
Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy. 査読有り
Omote N, Hashimoto N, Morise M, Sakamoto K, Miyazaki S, Ando A, Nakahara Y, Hasegawa Y.
Int J Chron Obstruct Pulmon Dis. 11 巻 ( 12 ) 頁： 3541-3547 2017年
-
Impact of mild to moderate COPD on feasibility and prognosis in non-small cell lung cancer patients who received chemotherapy 査読有り 国際誌
Omote Norihito, Hashimoto Naozumi, Morise Masahiro, Sakamoto Koji, Miyazaki Shinichi, Ando Akira, Nakahara Yoshio, Hasegawa Yoshinori
INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE 12 巻 頁： 3541 - 3547 2017年
-
Factors Affecting the Diagnostic Yield of Transbronchial Biopsy Using Endobronchial Ultrasonography with a Guide Sheath in Peripheral Lung Cancer. 査読有り
Okachi S, Imai N, Imaizumi K, Iwano S, Ando M, Hase T, Aso H, Morise M, Wakahara K, Ito S, Hashimoto N, Sato M, Kondo M, Hasegawa Y
Intern Med 55 巻 ( 13 ) 頁： 1705-12 2016年
-
The association of intravascular stromal cells with prognosis in high-grade neuroendocrine carcinoma of the lung 査読有り
Sekihara K, Hishida T, Ikemura S, Saruwatari K, Morise M, Kuwata T, Fujii S, Kojima M, Ochiai A, Funai K, Aokage K, Yoshida J, Tsuboi M, Ishii G
J Cancer Res Clin Oncol 142 巻 ( 5 ) 頁： 905-912 2016年
-
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy? 査読有り
Kato T, Morise M (equal first author), Ando M, Kojima E, Ogasawara T, Suzuki R, Shindoh J, Matsumoto M, Sugino Y, Ogawa M, Nozaki Y, Hase T, Kondo M, Saito H, Hasegawa Y
Can we predict the development of serious adverse events (SAEs) and early treatment termination in elderly non-small cell lung cancer (NSCLC) patients receiving platinum-based chemotherapy? 142 巻 ( 7 ) 頁： 1629-40 2016年
-
Comparison of the expression levels of molecular markers among the peripheral area and central area of primary tumor and metastatic lymph node tumor in patients with squamous cell carcinoma of the lung 査読有り
Udagawa H, Ishii G, Morise M, Umemura S, Matsumoto S, Yoh K, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A, Ohe Y
J Cancer Res Clin Oncol 141 巻 ( 8 ) 頁： 1417-25. 2015年
-
Presence of podoplanin-positive cancer-associated fibroblasts in surgically resected primary lung adenocarcinoma predicts a shorter progression-free survival period in patients with recurrences who received platinum-based chemotherapy
Koriyama H, Ishii G, Yoh K, Neri S, Morise M, Umemura S, Matsumoto S, Niho S, Ohmatsu H, Tsuboi M, Goto K, Ochiai A
J Cancer Res Clin Oncol 141 巻 ( 7 ) 頁： 1163-70 2015年
-
Drastic morphological and molecular differences between lymph node micrometastatic tumors and macrometastatic tumors of lung adenocarcinoma 査読有り
Aramaki N, Ishii G, Yamada E, Morise M, Aokage K, Kojima M, Hishida T, Yoshida J, Ikeda N, Tsuboi M, Ochiai A
142 巻 ( 1 ) 頁： 37-46 2015年
-
Clinicopathological significance of cancer stem-like cell markers in high-grade neuroendocrine carcinoma of the lung 査読有り
Morise M, Hishida T, Takahashi A, Yoshida J, Ohe Y, Nagai K, Ishii G
Journal of cancer research and clinical oncology 頁： 2015 May 12. [Epub ahead of print] 2015年
-
環境因子と呼吸器悪性腫瘍 招待有り
森瀬昌宏, 長谷川好規
呼吸と循環 62 巻 ( 10 ) 頁： 963-968 2014年
-
最新がん薬物療法学 小細胞肺癌 招待有り
森瀬昌宏, 後藤功一
日本臨床 増刊号 72 巻 ( 2 ) 頁： 346-349 2014年
-
Phase II study of erlotinib for previously treated patients with EGFR wild-type non-small-cell lung cancer, following EGFR mutation status reevaluation with the Scorpion Amplified Refractory Mutation System 査読有り
Morise M, Taniguchi H, Saka H, Shindoh J, Suzuki R, Kojima E, Hase T, Ando M, Kondo M, Saito H, Hasegawa Y
Mol Clin Oncol 2 巻 ( 6 ) 頁： 991-996 2014年
-
Low-dose Irinotecan as a Second-line Chemotherapy for Recurrent Small Cell Lung Cancer 査読有り
Morise M, Niho S, Umemura S, Matsumoto S, Yoh K, Goto K, Ohmatsu H, Ohe Y
Jpn J Clin Oncol 44 巻 ( 9 ) 頁： 846-51 2014年
-
Therapeutic Priority of the PI3K/AKT/mTOR Pathway in Small Cell Lung Cancers as Revealed by a Comprehensive Genomic Analysis 査読有り
9 巻 ( 9 ) 頁： 1324-31 2014年
-
特集 オンコロジーエマージェンシーと支持療法の進歩 抗がん剤による過敏反応，インフュージョンリアクション 招待有り
森瀬昌宏, 後藤功一
呼吸器内科 23 巻 頁： 261-267 2013年